Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Xconomy: New Crispr Fight: Old Friends Intellia, Caribou In License Dispute
LPNEWS

Xconomy: New Crispr Fight: Old Friends Intellia, Caribou In License Dispute

by xconomy.com posted 2weeks ago 25 views
An epic legal battle over CRISPR-Cas9 genome editing ended last year. But another one, smaller in scope and involving two long-time CRISPR allies, has quietly begun. Last October, Intellia Therapeutics (NASDAQ: NTLA) began an arbitration proceeding against Caribou Biosciences, alleging in a recent regulatory filing that its longstanding partner had broken the terms of a […]

In this article